Abstract
Donor intervention trials test treatments aimed at preserving organs in transplantation. Many such trials apply treatments to deceased organ donors before transplantation. Drawing on a recent National Academy of Medicine report, this review describes how such studies implicate the welfare of at least four different types of individuals who would not be considered human subjects under current regulations. I close by describing why protections of some sort ought to be extended to each of these four types of research bystanders.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
